← Back to Search

WILLOW for Suicide

N/A
Waitlist Available
Research Sponsored by Evidence-Based Practice Institute, Seattle, WA
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 weeks, 8 weeks, 12 weeks
Awards & highlights

Study Summary

The ultimate goal is to facilitate the delivery of empirically supported treatments (ESTs) for mental disorders and to improve client mental health outcomes. Toward this end, this Phase II SBIR proposal seeks to complete the development and testing of PracticeGround, a comprehensive software system designed to integrate with electronic health records, and that contains multiple methods of training clinicians in ESTs and delivering ESTs to clients, continuous progress monitoring of client outcomes, and clinical support tools to guide clinicians and clients through delivery of the necessary EST. The investigators will conduct an 18-week randomized controlled trial (N=80) comparing PracticeGround (n=40) to care-as-usual (n=40) in depressed outpatient clients. PracticeGround clinicians will have full access to the software. Study clinicians and clients will be assessed once every six weeks (baseline, 6, 12, and 18 weeks). To ensure generalizability of findings, the investigators will not control for natural therapy variations (e.g.,session frequency, medication use, etc.). Primary outcomes include: depression, psychological distress, treatment satisfaction (clients and clinicians), and treatment drop out. Secondary clinician outcomes include: extent of PracticeGround use with clients across clinicians' caseload.

Eligible Conditions
  • Suicide
  • Depression
  • Insomnia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 weeks, 8 weeks, 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 weeks, 8 weeks, 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
ASA-Monitoring and Feedback Version (ASA-MF)
Beck Depression Inventory (BDI-II)
Behavioral Activation for Depression Scale Short Form (BADS-SF)
+11 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: WILLOWExperimental Treatment1 Intervention
Clinicians have access to WILLOW's dynamic progress monitoring, clinical decision support, rich visual displays of client outcomes, online training modules in ESTs, just-in-time training for guided real-time assistance in delivering ESTs, educational videos, and a client portal
Group II: Treatment-as-UsualActive Control1 Intervention
Usual care without access to WILLOW.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Behavioral Activation for Depression, Cognitive Behavior Therapy for Insomnia, Collaborative Assessment and Management of Suicidality
2014
N/A
~150

Find a Location

Who is running the clinical trial?

Evidence-Based Practice Institute, Seattle, WALead Sponsor
8 Previous Clinical Trials
29,635 Total Patients Enrolled
6 Trials studying Suicide
29,321 Patients Enrolled for Suicide

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~14 spots leftby Apr 2025